SLSN

Business Context and Reporting Period

Company: Nanophase Technologies Corporation (Note: Metadata listed "SOLESENCE, INC." but filing text confirms "Nanophase Technologies Corporation").
Reporting Period: Fiscal year ended December 31, 2000.
Business Overview: Nanophase engineers and manufactures nanocrystalline materials for commercial applications in global markets. The company transitioned from a development stage to commercial production in 1997. Operations are conducted from facilities in Romeoville and Burr Ridge, Illinois.

Key Financial Metrics

Margins: The company operated at a loss. Cost of revenue was $4,754,485 (111% of total revenue), resulting in a negative gross margin. Operating expenses totaled $9,980,279.

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 200% to $4.27 million, driven primarily by a 239% increase in product revenue ($3.82 million vs. $1.13 million).
• Customer Concentration: Revenue concentration increased. Two customers (BASF and CIK) accounted for approximately 78.5% of 2000 revenue (68.5% and 10.0% respectively), compared to 53.4% from three customers in 1999.
• Expense Management: Selling, general, and administrative (SG&A) expenses decreased by 7% to $3.39 million, largely due to the absence of non-recurring restructuring costs present in 1999. Research and development (R&D) expenses increased 26% to $1.84 million due to new personnel and formulation development.
• Debt Incurrence: The company incurred $1.14 million in new debt in 2000 (a $650,000 promissory note from BASF and a $486,000 insurance financing agreement), whereas it had no debt in 1999.
• Loss Reduction: Net loss improved by $600,000 year-over-year, despite higher operating costs, due to significant revenue growth and interest income.

Outlook, Risks, and Contingencies

• Liquidity: Management believes current cash, investments, and interest income are sufficient to fund operations. However, future capital requirements may necessitate additional financing, which could be dilutive.
• Customer Dependence: The company faces significant risk due to reliance on a limited number of key customers. The loss of BASF or CIK could have a material adverse effect.
• Legal Proceedings:
  • Settled: A consolidated securities class action regarding the 1997 IPO was settled for $4.025 million, fully funded by directors' and officers' liability insurance.
  • Pending: A separate complaint by former preferred stockholders alleging fraud remains pending. The company intends to defend vigorously, though the outcome is uncertain.
• Tax Position: The company has a net operating loss carryforward of approximately $32.1 million. Due to ownership changes, utilization may be limited, and a portion may expire before use.
• Competition: Faces competition from larger chemical companies and development-stage firms with greater resources.

Investor Verification Checklist

• Customer Retention: Verify the status of contracts with BASF and CIK, which represent nearly 80% of revenue.
• Debt Service: Confirm the ability to service the new $1.14 million debt, specifically the BASF note repayable based on product volume ($1.37/kg).
• Legal Resolution: Monitor the status of the pending preferred stockholder lawsuit and potential liability exposure.
• Inventory Valuation: Review the allowance for excess inventory quantities, which was reduced by $168,627 in 2000 due to sales of previously reserved stock.
• Capital Needs: Assess the timeline for potential additional financing given the cumulative losses of $29 million since inception.